Oncology News

Template # 16 Headline: Among UK women aged 50 to 64 years with breast cancer, mortality rates were//

Preliminary results of a phase 1 trial for a novel vaccine that could eventually prevent triple-negative breast cancer exceeded expectations, based on data presented at San Antonio Breast Cancer Symposium.

Women with ovarian cancer from underrepresented groups have a higher likelihood of in-hospital mortality vs. hospice mortality compared with their white counterparts, according to study results published in Obstetrics & Gynecology.

Breast cancer screening and treatments in 2019 were both associated with more than 50% reduction in U.S. breast cancer mortality compared with interventions utilized over 4 decades ago, according to analysis results published in JAMA.

The FDA approved pembrolizumab in combination with chemoradiotherapy for the treatment of certain women with stage III to stage IVA cervical cancer.

Narjust Florez, MD, vividly recalls the urgent message she received from a colleague 3 years ago.

Vaccination against HPV and routine screening are the primary methods for cervical cancer prevention, and the convenience of at-home HPV tests may increase screening and lower cervical cancer prevalence in the U.S.

Women aged 35 years or younger with breast cancer had a higher risk for developing contralateral breast cancer compared with women older than 35 years, according to cohort study results published in JAMA Network Open.

All women with breast cancer should undergo genetic testing for BRCA1 and BRCA2 mutations, according to study findings presented at San Antonio Breast Cancer Symposium.

Asian, Black and Hispanic women with gynecologic cancers had a lower likelihood of being enrolled in clinical trials compared with white women, according to study findings published in JAMA Network Open.